DuPont Tightens 2026 Sales Outlook Amid Water Business Weakness Following Solid Q2 Results

Lede
DuPont (NYSE: DD) delivered a strong second quarter for 2026, exceeding quarterly guidance with adjusted EPS of $1.88 and raised full-year earnings projections. However, the company narrowed its annual sales forecast, citing weakness in its water business in the Middle East, triggering a pullback in its stock despite upbeat results.

Quarterly Performance and Outlook
On August 4, 2026, DuPont reported second-quarter net sales of $1.819 billion, marking a 4% increase year-over-year (organic sales growth also at 4%) and beating Wall Street consensus. GAAP income from continuing operations stood at $191 million, with GAAP EPS of $1.37 and adjusted EPS of $1.88. Operating EBITDA rose 6% to $448 million, resulting in an EBITDA margin of 24.6%. Transaction-adjusted free cash flow reached $326 million, reflecting an impressive 127% conversion. The company also announced plans to repurchase $250 million in shares during Q3 and confirmed the reclassification of its GICS code to Industrials (effective July 31) following its ongoing transformation. These results outpaced previous guidance and fueled optimism regarding operational execution.

Sales Forecast Narrowed on Water Business Lag
Despite the strong earnings beat, DuPont narrowed its full-year 2026 net sales outlook to a range of $7.16 billion–$7.19 billion, down slightly from the prior $7.16 billion–$7.22 billion projection. The revision reflects weaker-than-expected demand in its Middle East water business and a reduced boost from currency tailwinds. Meanwhile, full-year adjusted EPS guidance was raised modestly to $7.17–$7.32 from $7.02–$7.16.

Shareholder Reaction and Market Dynamics
The mixed signals sent DuPont shares lower in premarket trading, with an observed drop of roughly 5–7%. Investors appeared to react to the diminished sales outlook despite earnings strength, a dynamic characteristic of the “sell the news” phenomenon. The modest guidance bump and segment-level concerns appeared to temper enthusiasm, even as the company continues shifting toward higher-growth water, healthcare, and specialty materials.

Strategic Moves and Portfolio Focus
DuPont continues advancing its transformation with recent milestones: the Electronics business separation (spun off as Qnity in November 2025), the April 2026 Aramids divestiture (~$1.2 billion in cash), and classification as an industrial materials provider. During the latest quarter, DuPont also signaled interest in pursuing M&A in its water and healthcare segments. These moves underscore its strategy to concentrate on high-margin, resilient sectors as it reshapes its business model.

Significance and Investor Outlook
While DuPont’s Q2 performance underscores strategic progress and effective cost discipline, the narrowed sales guidance highlights that demand pressures persist, specifically in water solutions in certain regions. Investors may view the guidance revision as a prudent adjustment rather than a systemic issue, albeit one that tempers expectations for near-term growth. The company’s transformation journey—from plastics and aramids toward specialty chemistry and water solutions—remains intact, supported by elevated free cash flow and potential M&A activity.

Next Steps
Investors will likely monitor DuPont’s progress in its water and healthcare segments, clarity on how M&A discussions evolve, and whether sales momentum recovers in regions that disappointed this quarter. These dynamics will be pivotal for future guidance updates and valuation assessments.

Stock Price Note
At the time of this report, DuPont (ticker DD) was trading at approximately $138.80, reflecting a 0.95% increase as of August 27, 2026.